Solara Active Pharma Sciences Share Price Target 2026 — Analyst Forecast, Catalysts and Key Risks

Thu Apr 23 2026

The Solara Active Pharma share price target 2026 stands at Rs 592-682 as per analyst consensus — implying 22-40% upside from the current CMP of Rs 487. Investors tracking the Solara Active Pharma share price target 2026 need to understand the complete picture — the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Solara Active Pharma Sciences (SOLARA) achieves or misses this 12-month target. This article covers every dimension of the Solara Active Pharma share price target 2026 thesis — catalysts, risks, scenarios, analyst ratings, and key levels — updated April 2026.

Click Here — Get Free SEBI-registered Research on Solara Active Pharma Sciences on Univest.

Table of Contents

Solara Active Pharma Sciences Share Price Overview — April 2026

Company	Solara Active Pharma Sciences
NSE Symbol	SOLARA
Sector	API / CDMO / Regulated Markets / Recovery
CMP April 2026	Rs 487
52-Week High	Rs 782
52-Week Low	Rs 390
Market Cap	Rs 3,060 Cr
Trailing P/E	neg
Dividend FY26	Nil
Promoter Holding	30.5%
FII Holding	8.4%
12M Analyst Target	Rs 592-682
Upside from CMP	22-40%

Data from NSE/BSE and publicly available research. April 2026. Verify before investing.

Track live Solara Active Pharma Sciences price, FII/DII flows and analyst targets on the Univest Screener.

What Is Solara Active Pharma Sciences?

Get Free Analyst Research on Solara Active Pharma Sciences — Tap Here.

Solara Active Pharma Sciences (NSE: SOLARA) is recovering from FY24-25 FDA remediation and ibuprofen price compression. Management restructuring and new CDMO contracts are rebuilding revenue. PAT breakeven targeted in FY27.

Budget 2026-27 Impact on API

Budget 2026-27’s API PLI and regulated market pharma support measures benefit Solara’s API and CDMO recovery trajectory.

Solara Active Pharma share price target 2026 — Short, 12-Month and Long-Term Horizons

Horizon	Target	Key Assumption
Short-Term 3-6 Months	Rs 592	Q4 FY26 results beat and technical recovery
12-Month Consensus	Rs 592-682	FY27 earnings delivery and macro normalisation
Long-Term FY27-28	20-30% above 12M	Full earnings recovery and sector re-rating
Bear Case	Rs 390 zone	FY27 miss and extended FII selling

Compare Solara Active Pharma Sciences with sector peers live on the Univest Screener.

5 Growth Catalysts Supporting the Solara Active Pharma share price target 2026

1. India API Sector — Structural Growth Tailwind

India’s API sector is expanding at 12-18% annually — driven by rising incomes, urbanisation, government policy, and the India structural growth story. Solara Active Pharma Sciences’s market position within this sector creates compounding runway that underpins the Solara Active Pharma share price target 2026 consensus of Rs 592-682. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.

2. FY27 Earnings Recovery — Primary Re-Rating Catalyst

After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Solara Active Pharma Sciences to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the Solara Active Pharma share price target 2026 consensus of Rs 592-682. Track Q4 results live on the Univest Screener.

3. Competitive Moat — Defensible Market Position Built Over Decades

Solara Active Pharma Sciences holds a structural competitive moat in its API segment — brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles — the structural argument for the premium valuation embedded in the Solara Active Pharma share price target 2026 of Rs 592-682.

4. RBI Rate Cut Cycle — Reducing Cost of Capital

India’s RBI rate cut cycle commenced in 2026 reduces Solara Active Pharma Sciences’s borrowing costs and stimulates end-customer demand for API products. Lower interest rates improve EBITDA-to-PAT conversion — directly expanding EPS and supporting the Solara Active Pharma share price target 2026 of Rs 592-682 by making the earnings multiple more justifiable.

5. Budget 2026-27 Policy Alignment and Government Capex Support

Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Solara Active Pharma Sciences’s API business. Regulatory clarity and government spending certainty reduce operating risk — improving earnings visibility that directly supports the Solara Active Pharma share price target 2026 bull case.

Download the Univest iOS App or Android App for live Solara Active Pharma Sciences alerts and SEBI-registered research.

5 Risks That Could Impact the Solara Active Pharma share price target 2026

1. US Tariff and Global Macro Headwinds

The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Solara Active Pharma Sciences. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% — the key downside risk to the Solara Active Pharma share price target 2026 consensus of Rs 592-682.

2. Valuation at neg Requires Consistent Execution

At neg trailing P/E, Solara Active Pharma Sciences is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression — the most immediate risk to the Solara Active Pharma share price target 2026. The Rs 390 52-week low zone is the key support and stop-loss reference.

3. Competition Intensifying in API

Domestic and global competitors are investing aggressively in Solara Active Pharma Sciences’s API market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the Solara Active Pharma share price target 2026.

4. Input Cost and Supply Chain Volatility

Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates — creating downside risk to the Solara Active Pharma share price target 2026 of Rs 592-682.

5. FII Selling Risk — 8.4% Institutional Holding

With 8.4% FII ownership, Solara Active Pharma Sciences is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the Solara Active Pharma share price target 2026 analyst consensus of Rs 592-682.

Solara Active Pharma Sciences Bull Case vs Bear Case — Solara Active Pharma share price target 2026

Scenario	Price Target	Probability	Trigger
Bull Case	682	Medium	FY27 earnings beat, FII re-entry, sector re-rating
Base Case	Rs 592-682	High	FY27 in-line earnings, stable macro
Bear Case	Rs 390 zone	Low	FY27 guidance cut, prolonged FII selling

Solara Active Pharma Sciences Share Price Reference Table

NSE Symbol	SOLARA
CMP	Rs 487
52-Week High	Rs 782
52-Week Low	Rs 390
Market Cap	Rs 3,060 Cr
P/E	neg
Promoter	30.5%
FII	8.4%
Dividend FY26	Nil
Short-Term Target	Rs 592
12M Target	Rs 592-682
Upside	22-40%

Sources: NSE/BSE, Screener.in, publicly available analyst research. April 2026.

Analyst Ratings and Solara Active Pharma share price target 2026

Brokerage	Rating	Target	Key View
MOFSL	Buy	Rs 584	FY27 earnings recovery and API sector leadership
YES Securities	Buy	Rs 594	Quality execution — accumulate at support levels
Kotak Institutional	Add	Rs 560	Monitor Q4 FY26 guidance — maintain position
JM Financial	Neutral	Consensus	Await Q4 FY26 result clarity before adding

Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Solara Active Pharma Sciences.

How to Invest in Solara Active Pharma Sciences — 5 Steps

Step 1: Research on the Univest Screener

Search SOLARA on univest.in/screeners. Review quarterly results, FII/DII trend, promoter holding, and analyst consensus on the Solara Active Pharma share price target 2026.

Step 2: Identify Entry Level

Solara Active Pharma Sciences at Rs 487 has key support near Rs 390. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the Solara Active Pharma share price target 2026 recovery is Rs 592.

Step 3: Monitor Q4 FY26 Results

Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 682 — the bull case for the Solara Active Pharma share price target 2026.

Step 4: Position Sizing

Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.

Step 5: Track on the Univest App

Download the Univest iOS App or Android App for live price alerts and SEBI-registered research aligned with the Solara Active Pharma share price target 2026.

Conclusion — Solara Active Pharma share price target 2026

Solara Active Pharma Sciences (SOLARA) at Rs 487 offers 22-40% potential upside to the 12-month Solara Active Pharma share price target 2026 consensus of Rs 592-682. The bull case to 682 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 390 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Solara Active Pharma Sciences at current levels presents a monitored entry opportunity. For more Solara Active Pharma share price target 2026 analysis and peer comparisons, visit Univest Blogs.

Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions — Solara Active Pharma share price target 2026

Q: What is Solara Active Pharma Sciences share price target for 2026?

The 12-month Solara Active Pharma share price target 2026 analyst consensus is Rs 592-682 — implying 22-40% upside from CMP Rs 487. Bull case: 682. Bear case: Rs 390 zone. Track the live Solara Active Pharma share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.

Q: Is Solara Active Pharma Sciences a good buy at Rs 487?

This article does not constitute investment advice. At Rs 487, Solara Active Pharma Sciences offers 22-40% upside to the Solara Active Pharma share price target 2026 consensus of Rs 592-682. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.

Q: What is Solara Active Pharma Sciences 52-week high and low?

Solara Active Pharma Sciences’s 52-week high is Rs 782 and 52-week low is Rs 390. At the current CMP of Rs 487, the stock has corrected from its 52-week high — creating recovery potential for investors aligned with the Solara Active Pharma share price target 2026 thesis.

Q: What sector is Solara Active Pharma Sciences (SOLARA) in?

Solara Active Pharma Sciences operates in the API / CDMO / Regulated Markets / Recovery sector. India’s API sector is growing structurally — driven by rising incomes, government policy, and India’s consumption expansion — underpinning the Solara Active Pharma share price target 2026 bull case.

Q: What are the main risks for the Solara Active Pharma share price target 2026 thesis?

Key risks: US tariff macro headwinds, valuation at neg requiring consistent execution, competition in API, input cost volatility, and FII selling pressure (8.4% holding). Monitor quarterly earnings closely.

Q: What is Solara Active Pharma Sciences’s market cap?

Solara Active Pharma Sciences has a market cap of Rs 3,060 Cr as of April 2026. At the Solara Active Pharma share price target 2026 of Rs 592-682, the implied market cap would reflect 22-40% appreciation on the current base.

Q: What is Solara Active Pharma Sciences dividend for FY26?

Solara Active Pharma Sciences’s FY26 dividend is Nil. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the Solara Active Pharma share price target 2026 capital appreciation potential.

Q: How to buy Solara Active Pharma Sciences shares?

Buy Solara Active Pharma Sciences (SOLARA) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 390 support zone, and download the Univest App for SEBI-registered research on the Solara Active Pharma share price target 2026.